ARCHIVES

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

This article is from The Cancer Letter archive.

Vol. 30 No. 41 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

New Drugs And Older Ones In New Uses Show Progress Against Several Cancers

April 25, 2008

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

HHS lawyer tells of pressure to allow former NCI Director Richard Klausner to receive $40,000 prize.

May 21, 2004